Mol Ther.2022 Jan 22. (IF:11.454).

Cell Res.2021 Sep 24.(IF:25.617).

Acta Pharm Sin B.2021 11(9):2880-2899.(IF:11.413).

Theranostics.2021 Jan 1;11(2)(IF:11.556).

Mol Ther.2020 Nov 4;28(11)(IF:11.454).

Br J Pharmacol.2020 Aug;177(16)(IF:8.739).

Theranostics.2020 10(24):10908-10924.(IF:11.556).

Small.2020 Jul;16(30)(IF:13.281).

Nat Commun . 2019 Sep 20;10(1):4303.(IF:12.121).

J Immunother Cancer. 2019 7(1):209. (IF:8.676)

Mol Cancer. 2019 18(1):61.(IF:27.401).

J Exp Clin Cancer Res . 2019 Jan 10. (IF:11.878).

Mol Cell . 2018 Feb 1;69(3):480-492.e7.(IF:14.714).

Blood . 2017 Jun 15;129(24)(IF:11.841).

Nat Commun. 2016 7:11123. (IF:11.329).

Hepatology . 2015 Sep;62(3):801-15. (IF:11.711).

Nat Commun. 2015 Aug 24;6:8022. (IF:11.329).

Cancer Res . 2015 Mar 15;75(6):1080-90.(IF:9.323).

Cancer Reseach January 19, 2015(IF:9.323).

Nat Cell Biol. 2015 Jan;17(1):95-103. (IF:19.679).